<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Article</title>
</head>
<body>
    <article style="border: 2px solid black;padding: 10px;border-radius: 5px;display: flex;">
        <div>
        <img style="padding: 5px;" src="image/covid.jpg" alt="/">
        </div>
        <div>
        <h1>WHO recommends highly successful COVID-19....</h1>
        <p>22 April 2022 Statement Geneva Reading time: 2 min (592 words)
        Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission....</p>
        <time>22/04/2022 - time:7:05pm</time>
        <address>Md.Sahil Hossain</address>
    </div>
    </article>
    <article style="border: 2px solid black;padding: 10px;border-radius: 5px;display: flex;">
        <div>
        <img style="padding: 5px;" src="image/covid.jpg" alt="/">
        </div>
        <div>
        <h1>WHO recommends highly successful COVID-19....</h1>
        <p>22 April 2022 Statement Geneva Reading time: 2 min (592 words)
        Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission....</p>
        <time>22/04/2022 - time:7:05pm</time>
        <address>Md.Sahil Hossain</address>
    </div>
    </article>
</body>
</html>